COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,786 Articles (22,946 medRxiv, 8,840 bioRxiv)

Most recent first Previous |  Page 1257: Articles 12561-12570  | Next

In Vitro Activity of Cysteamine Against SARS-CoV-2 Variants Alpha, Beta, Gamma and Delta
Thoene, J. G., Gavin, R. F., Towne, A., Wattay, L., Ferrari, M. G., Pal, R.
10.1101/2021.10.02.462862 — Posted: 2021-10-04
Structure selected RBM immunogens prime polyclonal memory responses that neutralize SARS-CoV-2 variants of concern
Almanza, G., Kouznetsova, V., Clark, A. E., Olmedillas, E., Castro, A., Tsigelny, I. F., Wu, Y., Gao, G. F., Ollmann Saphire, E., Carlin, A. F., Zanetti, M.
10.1101/2021.10.01.462840 — Posted: 2021-10-04
Frequency of surveillance testing necessary to reduce transmission of the Delta variant of SARS-CoV-2
Elbanna, A., Goldenfeld, N.
10.1101/2021.10.01.21262806 — Posted: 2021-10-04
Dynamic Allostery Highlights the Evolutionary Differences between the CoV-1 and CoV-2 Main Proteases
Campitelli, P., Lu, J., Ozkan, S. B.
10.1101/2021.10.02.462863 — Posted: 2021-10-04
Hierarchical Gaussian Processes and Mixtures of Experts to Model COVID-19 Patient Trajectories
Cui, S., Yoo, E., Li, D., Laudanski, K., Engelhardt, B.
10.1101/2021.10.01.462821 — Posted: 2021-10-04
Characterization and Structural Prediction of ORF10, ORF7b, ORF7a, ORF6, Membrane Glycoprotein, and Envelope Protein in SARS-CoV-2 Bangladeshi Variant through Bioinformatics Approach
Debnath, P., Khan, U., Khan, M. S.
10.1101/2021.10.01.452232 — Posted: 2021-10-04
SARS-CoV-2 multi-variant graphene biosensor based on engineered dimeric ACE2 receptor
D'Agostino, M., Pavoni, E., Romagnoli, A., Ardiccioni, C., Motta, S., Crippa, P., Biagetti, G., Notarstefano, V., Barocci, S., Costabile, B. K., Colasurdo, G., Caucci, S., Mencarelli, D., Turchetti, C., Farina, M., Pierantoni, L., La Teana, A., Al Hadi, R., Chinappi, M., Trucchi, E., Mancia, F., Morozzo della Rocca, B., D'Annessa, I., Di Marino, D.
10.1101/2021.10.02.21264210 — Posted: 2021-10-04
The paradox of the COVID-19 pandemic: the impact on patient demand in Japanese hospitals
Ii, M., Watanabe, S.
10.1101/2021.10.01.21264447 — Posted: 2021-10-04
Risk factors for infection, predictors of severe disease and antibody response to COVID-19 in patients with rheumatic diseases in Portugal - a multicentre, nationwide study
Cruz-Machado, A. R., C. Barreira, S., Bandeira, M., Veldhoen, M., Gomes, A., Serrano, M., Duarte, C., Rato, M., Fernandes, B. M., Garcia, S., Pinheiro, F., Bernardes, M., Madeira, N., Miguel, C., Torres, R., Bento Silva, A., Pestana, J., Almeida, D., Mazeda, C., Cunha Santos, F., Pinto, P., Sousa, M., Parente, H., Sequeira, G., Santos, M. J., Fonseca, J. E., C. Romao, V.
10.1101/2021.10.01.21264428 — Posted: 2021-10-03
Initial SARS-CoV-2 viral load is associated with disease severity: a retrospective cohort study
Souverein, D., van Stralen, K., van Lelyveld, S., van Gemeren, C., Haverkort, M., Snijders, D., Soetekouw, R., Kapteijns, E., de Jong, E., Hermanides, G., Aronson, S., Wagemakers, A., Euser, S.
10.1101/2021.10.01.21264412 — Posted: 2021-10-03 Discussion: Onsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).